Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)

NCT00885352 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

313

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin
DRUG: Comparator: Placebo
DRUG: Pioglitazone
DRUG: Metformin
DRUG: Glipizide

Sponsor

Merck Sharp & Dohme LLC